Mean PAM-Hb levels were 99.5 pmol g−1 Hb for breast cancer patients in the C500 group and 124.0 pmol g−1 Hb for the C600 group after the first course (Fig. 2). This evidence concerns the gene GSTM1 and breast carcinoma.